Home › Funds › Squadron Capital Management LLC › IKT

Squadron Capital Management LLC position in IKT

INHIBIKASE THERAPEUTICS INC · Health Care

Squadron Capital Management LLC reported holding 3,000,000 shares of IKT (INHIBIKASE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$6.1M, representing 2.38% of its reported portfolio and ranking #12 among its reported holdings. Squadron Capital Management LLC has disclosed IKT holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)3.00M sh
Reported value held$6.09M
Portfolio Weight2.38%
First reportedQ4 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Squadron Capital Management LLC's IKT position evolved

Squadron Capital Management LLC first disclosed a stake in IKT in Q4 2025 at 4,225,000 shares (US$8.7M). Across 3 filings, Squadron Capital Management LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 3,000,000 shares valued at US$6.1M — a reduction of -500,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 4.22M $8.66M New
Q1 2026 3.50M $5.88M Reduce
Q2 2026 3.00M $6.09M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IKT and 13F data

IKT (INHIBIKASE THERAPEUTICS INC) is a Health Care company. 69 other funds we track also report a position in IKT — the largest reported positions include Sands Capital Alternatives, LLC (US$26.4M), Soleus Capital Management, L.P. (US$22.1M), Trails Edge Capital Partners, LP (US$18.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IKT

All IKT fund holders →

FAQ

How long has Squadron Capital Management LLC held IKT?

Squadron Capital Management LLC has disclosed IKT holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Squadron Capital Management LLC's current position in IKT?

As of Q2 2026, Squadron Capital Management LLC holds 3.00M shares of IKT (INHIBIKASE THERAPEUTICS INC), valued at $6.09M, representing 2.38% of its reported portfolio and ranking #12.

Has Squadron Capital Management LLC been buying or selling IKT?

In the latest 13F filing (Q2 2026), Squadron Capital Management LLC reduced its position in IKT.

Which other funds hold IKT?

Other major institutional holders of IKT include Sands Capital Alternatives, LLC, Soleus Capital Management, L.P., Trails Edge Capital Partners, LP, among 69 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.